SELECTIS HEALTH, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SELECTIS HEALTH, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $3.62M | Apr 16, 2019 |
| FY2018 | Dec 31, 2017 | $3.13M | Apr 16, 2019 |
| FY2013 | Jun 30, 2013 | $3.14M | Oct 15, 2013 |
| FY2013 | Jun 30, 2012 | $3.11M | Oct 15, 2013 |
| FY2011 | Jun 30, 2011 | $5.52M | Feb 19, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.44M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $39.49M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $36.78M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $40.60M | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | $29.29M | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $20.93M | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | $6.93M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.62M | Jul 10, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.02M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($2.42M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($3.97M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($2.40M) | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | ($2.25M) | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $2.96M | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | ($861.6K) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($1.99M) | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | ($3.00M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($1.15M) | Apr 24, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.56M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($2.73M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($8.96M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($286.6K) | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | ($729.0K) | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $3.37M | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | $1.30M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $340.0K | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | $464.5K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($57.7K) | Apr 24, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.88M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($1.82M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $536.7K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($305.1K) | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | ($270.9K) | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $2.73M | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | $868.9K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $108.2K | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | $218.3K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($507.0K) | Apr 24, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $443.6K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $36.1K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $29.8K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $222.4K | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | $519.6K | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $985.7K | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | $1.67M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $763.3K | Jul 10, 2020 |
| FY2015 | Dec 31, 2014 | $5.71M | Apr 15, 2016 |
| FY2014 | Dec 31, 2013 | $3.50M | Apr 15, 2015 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.58M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $33.45M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $40.67M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $42.49M | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | $46.92M | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $45.93M | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | $39.88M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $38.30M | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | $38.23M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $37.54M | Apr 24, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.79M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $38.86M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $43.64M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $41.54M | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | $43.82M | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $42.72M | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | $39.51M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $37.31M | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | $35.95M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $33.01M | Apr 24, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.21M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($5.41M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | ($2.96M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2022 | $952.8K | Apr 15, 2025 |
| FY2021 | Dec 31, 2021 | $3.10M | Aug 26, 2022 |
| FY2021 | Dec 31, 2020 | $3.41M | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | $571.2K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.18M | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | $2.47M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $4.71M | Apr 24, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.08M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $1.08M | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | $1.08M | Apr 15, 2026 |
| FY2024 | Dec 31, 2022 | $1.08M | Apr 15, 2025 |
| FY2023 | Dec 31, 2021 | $1.08M | Oct 4, 2024 |
| FY2022 | Dec 31, 2020 | $1.08M | Jun 30, 2023 |
| FY2021 | Dec 31, 2019 | $379.5K | Aug 26, 2022 |
| FY2016 | Dec 31, 2014 | $1.75M | Apr 28, 2017 |
| FY2015 | Dec 31, 2013 | $1.75M | Apr 15, 2016 |
| FY2013 | Jun 30, 2013 | $0 | Oct 15, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($21.24M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($20.19M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($17.75M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($13.74M) | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | ($11.32M) | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | ($9.04M) | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | ($11.96M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($11.07M) | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | ($9.05M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($6.02M) | Apr 24, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.01M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $680.3K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $1.48M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $1.42M | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | $3.94M | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | $3.57M | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | $641.2K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.10M | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | $154.6K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $578.2K | Apr 24, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $6.31M | Aug 26, 2022 |
| FY2021 | Dec 31, 2020 | $19.30M | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | $37.98M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $36.60M | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | $35.12M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $32.04M | Apr 24, 2018 |
| FY2016 | Dec 31, 2015 | $35.82M | Apr 28, 2017 |
| FY2013 | Dec 31, 2013 | $7.27M | May 16, 2014 |
| FY2013 | Jun 30, 2013 | $532.9K | Oct 15, 2013 |
| FY2013 | Jun 30, 2012 | $862.0K | Oct 15, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | (1) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | 1 | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 24, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | (1) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 24, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.07M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 3.07M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 3.07M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 3.07M | Oct 4, 2024 |
| FY2022 | Dec 31, 2021 | 3.00M | Jun 30, 2023 |
| FY2021 | Dec 31, 2020 | 2.69M | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | 27.44M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 26.80M | Jul 10, 2020 |
| FY2018 | Dec 31, 2017 | 26.30M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 25.03M | Apr 24, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2015 | $440.8K | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | $414.6K | Apr 15, 2016 |